本文来源:时代财经4月1日,国家药品监督管理局医疗器械批准证明文件送达信息显示,四环医药旗下渼颜空间生物科技(吉林)有限公司的注射用聚己内酯微球面部填充剂获批。这是国内第三款获批的少女针。此前,国内已获批的同类产品仅有两款,分别为华东医药的伊妍仕和山东采采医疗科技有限公司的塑妍真·真妤。(时代财经 文若楠)
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.